Quick Answer
DocGo Inc. reported R&D Expense of $13.56 million for fiscal year 2025.
DocGo Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $13.56M | +17.0% |
| 2024 | $11.59M | +6.7% |
| 2023 | $10.86M | +101.7% |
| 2022 | $5.38M | +62.2% |
| 2021 | $3.32M | +179.1% |
| 2020 | $1.19M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.19M | +1.5% | +8.0% |
| June 30, 2025 | $2.96M | +24.8% | -18.7% |
| March 31, 2025 | $3.64M | +52.3% | +15.7% |
| September 30, 2024 | $3.15M | -2.8% | +32.8% |
| June 30, 2024 | $2.37M | -8.0% | -0.8% |
| March 31, 2024 | $2.39M | +28.2% | -26.2% |
| September 30, 2023 | $3.24M | +135.6% | +25.7% |
| June 30, 2023 | $2.57M | +124.2% | +38.1% |
- DocGo Inc. showed an increase of +17.0% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, DocGo Inc.’s r&d expense has grown by 1040.2% (from $1.19 million to $13.56 million).
- The most recent figure is from DocGo Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: